Surprisingly, however, the analysis of clinical trials conducted since 1990 found that the increase in placebo responses occurred only in trials conducted wholly in the U.S.; trials conducted in Europe or Asia showed no changes in
placebo responses over that period.
Not exact matches
In comparison, men who received the
placebo did not change their questionnaire
responses significantly
over the course of the year - long study.
This is extremely interesting since in this study, the people in the
placebo group didn't eat for
over 2 hours before the workout, then completed a 2 hour workout, then did not eat for another 9 hours, essentially meaning they were fasted for
over 13 hours and they still had the same anabolic
response to their workout as the people who drank a protein shake during their workout then had two more protein shakes once they were done their workout!
The children were randomly assigned either a
placebo or a homeopathic remedy and their
response studied
over 10 days.
According to this study, the
response to
placebos in clinical trials for neuropathic pain has been rising
over time.
The SPIN was responsive to change in symptoms
over time and reflected different
responses to active drugs v.
placebo.
Secondary efficacy analyses showed a significant advantage of agomelatine
over placebo in terms of
response (with no effect for remission).